Skip to main content
OpenTrials
Completed

NCT Number: NCT04376918

Bag-Valve-Guedel Adaptor Vs Common Face Mask for the Ventilation of Anesthetized Bearded Men

Ventilation of a bearded patient with the commonly used face mask has low efficiency because of difficulties to achieve a tight seal around the mouth and nose. The purpose of this study is to evaluate the efficacy of a novel bag valve Guedel adaptor (BVGA) that enables the direct connection of a bag valve device to a Guedel - eliminating the need for a face mask in anesthetized bearded men.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Haddasah Medical Center

Jerusalem, Israel

About this study

Ventilating a patient using a bag valve and a face mask is not easy to perform, especially for a long period of time, and mandates experience and strength by the care giver. The need for a tight seal around the mouth and nose is a major challenge especially if the patient has a beard. Nevertheless, the face mask is the only approved respiratory support that medics and other basic care givers are allowed to use in the out-of-the-hospital setting, and only physicians and paramedics are allowed to use more advanced techniques, providing a definite airway. Thus, despite its lower effectiveness, the bag valve mask technique is the most commonly used in the field. We have shown previously that the BVGA provides significantly more efficient (less leak) ventilation compared to a facemask, in a randomized, cross-over (BVGA vs mask) controlled clinical trial (NCT02768246) with healthy bearded volunteers that were awake and breathed spontaneously.

The purpose of this study is to evaluate the safety and efficacy of the BVGA compared to a classic facemask in anesthetized bearded volunteers.

Study Design:

Prospective, randomized (sequence randomization), controlled (cross over). The study population will include ASA 1 or 2patients that are planned to undergo elective surgery under general anesthesia with non-depolarizing muscle relaxants. These will include 45 men with beards, and 14 men without beards or women

All subjects will sign an informed consent before participation and will be randomized by sequence (BVGA followed by Mask or Mask followed by BVGA). The physician will initiate anesthesia induction with a face mask according to normal procedures. Experimental phase: According to the sequence of devices determined in the randomization, the physician will then place the first device for 2 minutes, and then replace it with the second device for 2 minutes. The devices will be connected to the operating ventilation machines and physiological and respiratory parameters will be monitored continuously. During the experimental phase, a study assistant will note if the physician used 1 or 2 hands during the ventilation with the experimental devices (BVGA/mask).

The physician will then continue the anesthesia procedures as planned. The physician will complete a questionnaire related to the use of the BVGA in comparison to the standard mask.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Beards men with different levels of beard fullness, men without beards, or women
  • planned to undergo elective surgery with endotracheal intubation using non-depolarizing neuromuscular blocking agents
  • ASA 1 or 2
  • BMI ≤30

Exclusion criteria

  • Pregnant women
  • ASA>2
  • Presence of facial fractures or injuries.
  • Expected to suffer from aspiration and requiring rapid sequence induction
  • Edentulous or unstable teeth
  • Morbid obesity
  • Suspected difficult intubation
  • Suspected difficult ventilation (except of the presence of beard)
  • If an unexpected difficulty in ventilation will arise during induction, patient will be excluded from study.
  • Worker from Hadassah Medical Center

Treatment and study plan

Begin with BVGA

Device

Device: BVGA The BVGA enables the direct connection of a bag valve device to a Guedel, eliminating the need for a face mask during ventilation

Other Names:

  • Bag Valve Guedel Adaptor Device: Face Mask Classic face mask

Begin with Face-mask

Device

Device: BVGA The BVGA enables the direct connection of a bag valve device to a Guedel, eliminating the need for a face mask during ventilation

Other Names:

  • Bag Valve Guedel Adaptor Device: Face Mask Classic face mask

Primary outcomes

  1. Tidal Volume

    Time frame: 2 minutes

    Tidal volume will be monitored while the volunteer breathes through the BVGA or the face mask. The second minute of each of the interventions will be used for the data analysis.

Secondary outcomes

  1. End tidal CO2 levels (EtCO2)

    Time frame: 2 minutes

    EtCO2 will be monitored while the volunteer breathes through the BVGA or the face mask. The second minute of each of the interventions will be used for the data analysis.

  2. Ease of use

    Time frame: 30 minutes

    The number of hands (1 or 2) the physician had to use during the ventilation procedure while using each device (mask or BVGA)

Sponsors and collaborators

Lead sponsor

Hebrew University of Jerusalem

Other

Collaborators

  • Hadassah Medical Organization

Registry information

Official study title

Evaluating the Safety and Efficacy of the Bag-Valve-Guedel Adaptor in Anesthetized Bearded Men in Comparison to the Standard Face Mask - a Prospective, Randomized Cross-over Clinical Trial

Acronym: BVGA02

Important dates

Study start
2021
Primary completion
2023
Study completion
2023
First posted
May 6, 2020
Registry last updated
Mar 12, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.